Revelation Biosciences, Inc.
REVB· Nasdaq
Released Aug 23, 2021, during market hours
10-Q filed Aug 23, 2021, 54 days after period end · 0001213900-21-044217
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Net Income | -$2.47M | -$521.00 |
| EPS Diluted | -$0.39 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Revelation Biosciences, Inc. · CIK 1810560 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 23, 2021 · 54 d after period end